The Scientist

» NIH funding, immunology and microbiology

Most Recent

A mouse study reveals a causal link between changes in intestinal microbiota and increasing inflammation as the rodents age.

0 Comments

Mice exposed to low doses of penicillin in utero or as young pups exhibited long-term behavioral differences not seen in their non-exposed counterparts, according to a study.

0 Comments

image: Viral Trigger for Celiac Disease?

Viral Trigger for Celiac Disease?

By | April 6, 2017

A common, seemingly benign human virus can trigger an immune response that leads to celiac disease in a mouse model, researchers show. 

3 Comments

Recolonizing middle-aged animals with bacteria from younger ones kept killifish alive longer than usual, researchers report.

0 Comments

image: Trump Meets with HHS, NIH Brass

Trump Meets with HHS, NIH Brass

By | April 5, 2017

President Donald Trump, HHS Secretary Tom Price, and NIH Director Francis Collins discussed the opioid crisis and retaining young researchers in the biomedical research enterprise, among other things, according to a White House official.

0 Comments

Both Democrats and Republications criticize the Trump administration’s plan to cut funding for biomedical research.

0 Comments

image: TS Picks: April 3, 2017

TS Picks: April 3, 2017

By | April 3, 2017

USDA posting few animal inspections; HHS secretary proposes cutting indirect research expenses; science journalism vs. fake news

1 Comment

image: Gel Scaffolds for Delivery of Immunotherapies

Gel Scaffolds for Delivery of Immunotherapies

By | April 1, 2017

Using biocompatible polymers to carry cancer immune therapies directly to the tumor

0 Comments

image: Making CAR T-Cell Therapy Safer

Making CAR T-Cell Therapy Safer

By | April 1, 2017

Following a spate of patient deaths in clinical trials testing modified T cells for the treatment of cancer, researchers work to reduce the treatment’s toxicity without sacrificing efficacy.

0 Comments

image: Neoantigens Enable Personalized Cancer Immunotherapy

Neoantigens Enable Personalized Cancer Immunotherapy

By | April 1, 2017

Tumors’ mutations can encode the seeds of their own destruction, in the form of immunogenic peptides recognized by T cells.

1 Comment

Popular Now

  1. Consilience, Episode 3: Cancer, Obscured
  2. RNAi’s Future in Drug-Target Screening
    News Analysis RNAi’s Future in Drug-Target Screening

    A recent CRISPR study contradicted years of RNA interference research on a well-studied cancer drug target. But is it the last nail in the coffin for RNAi as a screening tool? 

  3. A History of Screening for Natural Products to Fight Cancer
  4. Human Cord Plasma Protein Boosts Cognitive Function in Older Mice
AAAS